← Back to Search

High Intensity Focused Ultrasound for Prostate Cancer

Phase 2
Waitlist Available
Led By Tarik Benidir, MD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Males who are ≥ 18 years of age
Eastern Cooperative Oncology Group Performance Status of 0-3
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights

Study Summary

This study will investigate the efficacy of focal high intensity focused ultrasound (HIFU) in patients with localized radiorecurrent prostate cancer. This study will also investigate the change in participant quality of life after HIFU therapy as compared to before HIFU therapy.

Eligible Conditions
  • Prostate Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
In-field failure-free survival
Secondary outcome measures
Change in quality of life metrics
Complication rates
Local failure-free survival
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: High Intensity Focused UltrasoundExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,344 Previous Clinical Trials
716,420 Total Patients Enrolled
10 Trials studying Prostate Cancer
3,818 Patients Enrolled for Prostate Cancer
EDAP-TMS Focal OneUNKNOWN
Tarik Benidir, MDPrincipal InvestigatorUniversity of Florida
1 Previous Clinical Trials
147 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~17 spots leftby Aug 2027